Table 3 Effect of changing operational strategy compared to a baseline strategy of three rounds mass test and treat with artemether-lumefantrine at 40 % coverage per round of all ages of the population with 60 days between rounds

<10

0.0

(−23.7, 107.4)

−6.1

(−32.6, 44.7)

−8.7

(−31.6, 43.4)

0

(−28.9, 56.3)

−2.4

(−30.0, 42.6)

−2.9

(−26.3, 48.9)

5.5

(−24.7, 112.6)

7.4

(−23.2, 86.1)

5.8

(−23.9, 111.3)

1.6

(−28.9, 64.2)

−5.5

(−30.0, 43.2)

10–24

65.8

(17.5, 107.1)

−19.7

(−38.8, −1.0)

−37.6

(−53.2, −17.8)

−15.1

(−32.5, 6.7)

−18.6

(−43.2, −4.4)

−26.2

(−40.8, −2.8)

60.8

(20.6, 95.2)

43.9

(4.1, 84.4)

40.9

(−2.9, 74.3)

−0.8

(−20.1, 28.1)

−25.5

(−41.4, −7.4)

>24

47.5

(42.7, 56.3)

−25.6

(−33.1, −16.8)

−44.2

(−49.9, −36.6)

−18.2

(−27.5, −11.1)

−21.4

(−31.8, −13.6)

−25.3

(−33.3, −17.2)

46.3

(37.2, 51.34)

36.8

(29.1, 49.7)

29.8

(19.4, 38.1)

2.9

(−3.1, 9.8)

−25.7

(−34.5, −17.2)